Skip to main content

Prevalence of congenital malformations at the “les Orangers” maternity and reproductive health Hospital of Rabat: descriptive study of 470 anomalies



Congenital malformations are described in about 3% of live births and 20% of stillbirths in the industrialized countries.

The prevalence of congenital anomalies in developing countries, including Morocco, is not well known at the national level.

The aim of our study is to conduct a descriptive exploratory analysis of congenital malformations cases diagnosed at the “Les Orangers” Maternity and Reproductive Health Hospital in Rabat.


We collected all the cases of congenital malformations diagnosed at the “Les Orangers” Maternity and Reproductive Health Hospital in Rabat, from January 1st, 2011 to June 31st, 2016.

Data were reported on pre-established sheets and on a registry of malformations. Total and specific prevalences were calculated for each malformation. A principal component analysis (PCA) was then conducted followed by a Varimax rotation in order to identify the different associations of malformations in our series.


We registred 245 cases of congenital malformations out of a total of 43,923 recorded births; a prevalence of 5.58 per thousand births of which 19.2% were FDIU (fetal deaths in utero).

A polymalformative syndrome was found in 26.5% of cases which makes a total number of 470 anomalies. The musculoskeletal anomalies predominate with a rate of 33%, followed by neurological abnormalities 18%, of whom 31% were hydrocephalus, 26.2% anencephaly, and 20.24% spina bifida. Malformations of the eye, ear, face and neck were described in 12% of the cases, while genetic abnormalities were observed in 8,5% of which 87.5% represented Down syndrome.

The antenatal diagnosis of congenital malformations was performed in 28.6% of cases.


Our study provides a general overview of the epidemiological situation related to different types of congenital anomalies for a specific area in Morocco.

It represents a database that should be complemented by other multicenter studies and the implementation of a national registry to determine the prevalence of congenital malformations at a national level.

Peer Review reports


Malformations are often described as congenital defects whether they are diagnosed at birth or later. Thus, the real defects or “primary defects” should be distinguished from distortions and disruptions that are secondary to an extrinsic factor and called “secondary defects”. This distinction is essential to establishing genetic counseling, as it allows evaluating the risk of malformation occurrence or recurrence and proposing appropriate prevention.

A congenital malformation (CM) is a morphological abnormality that results from an abnormal development process during the formation of the embryo or fetus. Depending on their types, locations and sizes, malformations can cause functional, psychological, or aesthetic disorders that presently affect more than 8 out of every 1000 children [1, 2].

Congenital malformations account for about 3% of live births and 20% of stillbirths. In industrialized countries they represent a frequent cause of infant mortality, morbidity and disability [3,4,5,6].

According to the WHO (World Health Organization), about half of congenital anomalies cannot be attributed to a specific cause. Some risk factors or causes are often associated and there are three etiological groups: [7].

  • Genetic intrinsic causes (10–15%): chromosomal, genetic or epigenetic;

  • Extrinsic environmental causes (10–15%): infectious agents (rubella, toxoplasmosis, cytomegalovirus), physical (ionizing radiation, hyperthermia), medicinal (isotretinoin, thalidomide, antiepileptics), metabolic (maternal diabetes, folic acid deficiency), toxic (tobacco, fetal alcohol syndrome), mechanical (oligoamnios);

  • Multifactorial causes (20–25%)

Congenital malformations are one of the leading causes of morbidity and neonatal mortality in all developing countries in general and in Morocco in particular. According to the results of the last National Survey of Population and Family Health (ENPSF) 2017–2018, the neonatal mortality rate in Morocco is 13.56 per thousand live births with an infant mortality rate (less than 1 year) of 18% [8]. Unfortunately, the prevalence of congenital malformations and their causes are not yet established at the national level due to the lack of a nation-wide congenital malformations monitoring system.

Consequently, the aim of the present study is to conduct a descriptive exploratory analysis of CM cases diagnosed at “Les Orangers” Maternity and Reproductive Health Hospital in Rabat.


Study design

This is a descriptive epidemiological study of CM cases diagnosed prenatally by obstetrical ultrasound and / or at birth during a routine clinical examination of all newborn infants in the “Les Orangers” Maternity Hospital and Reproductive Health of Rabat, Morocco during the period from January 1st, 2011 to June 31st, 2016.

This hospital is a level 3-facility with an average annual delivery rate of 8000. It receives parturient/laboring women from all over Morocco. In addition, it ensures the monitoring of high risk or as well as normal pregnancies by carrying out antenatal checkups and obstetric ultrasounds.

All pregnant women whose fetuses or newborns had a malformation were included, regardless of the term or outcome of the pregnancy.

Cases where the malformation was suspected on obstetrical ultrasound but not confirmed at birth were excluded as were the cases of refusal to participate in the survey.

Parents were informed about the terms and objectives of the study and their consent was obtained. A significant proportion of women included in our study were illiterate and for cultural reasons they prefer to give an oral agreement without signing. At least 3 persons from the medical have witnessed each oral consent. Furthermore, oral explanations and a written document describing the information relevant to their consent and the contact details of the researcher were provided to each patient. The ethics committee accepted this procedure.

Data collection

The collection of information was carried out by a doctor and reported on pre-established sheets and on “Les Orangers” Maternity’s Malformations Register.

To determine the prevalence, we opted for the international definitions used by EUROCAT and the ICBDSR:

  • Total prevalence: total number of cases (live births, stillbirths and medical interruptions of pregnancy) divided by the total number of births (live births and stillbirths).

  • Prevalence of live births: number of children born alive with the anomaly divided by the total number of live births [9, 10].

To classify the malformations we used the following definitions of malformation types:

  • “Isolated” malformation: any malformation not associated with a chromosomal abnormality or other major abnormality of another system.

  • Polymalformations: when there is an association of at least two malformations. They can correspond to three different situations [11]:·

    1. 1)

      A sequence: is a set of anomalies resulting from a single anomaly or a mechanical factor: For example the oligoamnios sequence or Potter’s sequence, following a lack of amniotic fluid.

    2. 2)

      A malformative syndrome: is a set of unrelated abnormalities, all derived from the same cause and not corresponding to a sequence, e.g., Down syndrome.

    3. 3)

      An association: is the unplanned occurrence of at least two unrecognized malformations as a sequence or syndrome, e.g., VACTER syndrome, acronym for “vertebral, anal, cardiac, tracheal, esophageal, radial and / or renal malformations”.

Statistical analysis

Data entry and statistical analysis was carried out using SPSS.18.0 software. Total and specific prevalences were calculated for each malformation. Principal component analysis (PCA) followed by Varimax rotation was performed. The selected factors had a true value greater than 1.25. The items retained within each factor had a value greater than or equal to 0.40 within the factor and a value below 0.40 within the other factors. A forced structure with three inter-correlated factors was selected for each malformation.


During the study period, 43,923 births were included, of which 245 cases had one or more congenital malformations, which represents a prevalence of 5.58 per thousand births (or 55.8 per 10,000 births). Of these cases, 96.7% had one or more clinically visible malformations, 51.9% were males and 43.5% were females with a sex ratio of 1.19.

A polymalformative syndrome was found in 26.5% of cases which explains why the total number of identified congenital malformations, with 470 anomalies, exceeds the number of patients.

Within these 470 reported CMs, musculoskeletal malformations accounted for 33% of cases followed by neurological malformations with a rate of 18%, and then abnormalities of the eye, ear, face and neck at 12%. Genetic abnormalities represented 8.5%. (The different types and subtypes of recorded malformations are summarized in Tables 1 and 2).

Table 1 The different types of congenital malformations according to the International Classification ICD-10 [12]
Table 2 Prevalence of types and subtypes of congenital malformations identified at “Les Orangers” Maternity and Reproductive Health Hospital of Rabat, Morocco

Malformation diagnosis was performed in more than two thirds of cases (71.4%) at birth during a systematic newborn infant’s clinical examination.

The antenatal diagnosis, which represents 28.6% of cases, was performed mainly in the second and third trimesters with a proportion of respectively 47% (33 cases) and 48.5% (34 cases). The ultrasound diagnosis during the first trimester only covered 5.7% (4 cases).

The factorial analysis has identified a seven-factor structure (associations of malformations) accounting for 21.28% of the overall variance (Table 3). The first three associations accounted for more than 50% of the total variance.

  • The first factor is an association of congenital malformations corresponding to Trisomy 8, pelvic kidney, microphthalmia, sacral agenesis, epidermal sinus, agenesis of nose cartilage and clubfoot.

  • The second factor is an association of congenital malformations corresponding to craniosynostosis, funnel chest, limb asymmetry, scoliosis, cleft palate and ureteral dilatation.

  • The third factor is an association of congenital malformations corresponding to invisible bladder, absence of thalami, thin thorax, hyperflexion limbs, cardiomegaly, amniotic flanges and polycystic kidney.

Table 3 Analysis of congenital malformations profiles detected at the “Les Orangers” Maternity and Reproductive Health Hospital, Rabat, Morocco


In the present study, a prevalence of 5.58 per thousand births (0.56% or 55.8 per 10,000 births) was reported. This prevalence is consistent with that of other African countries.

Indeed, a retrospective analytical study carried out in the city of Lubumbashi, Congo between 2010 and 2011 across 11 maternity clinics showed a prevalence of 58.4 per 10,000 births (0.58%) [13]. A similar prevalence (0.57%) was also found in a multicenter prospective study conducted at Clinical Universities of Kinshasa [14].

In addition, a study conducted in Egypt between 1995 and 2009 showed a frequency of CMs of 2% [15].

In developed countries, where congenital anomalies are systematically reported in national registries, the prevalence of congenital malformations is 6 times higher than the one we have reported in our study. In France, for example, the estimated prevalence of congenital malformations at birth is 3–4% [16] while it stands at 3–5% in Canada and the United States [17, 18].

Thus, the prevalence reported in our study is probably below the real value due to possible under-reporting of malformations in addition to the fact that some late-onset malformations, posterior to neonatal period, were not accounted for. This observation is found in a majority of studies carried out in developing countries [19, 20].

The most frequently reported malformations in our series were musculoskeletal abnormalities, CMs of nervous system and CMs of eye, ear, face and neck. These 3 types of malformations represent 60% of reported cases.

Musculoskeletal abnormalities were the most frequently reported with a rate of 33% (equivalent to 35 per 10,000 total births), of which 17.4% of clubfoot, 7.7% of omphalocele, 7.1% of supernumerary fingers, followed by short limbs with a rate of 6.4%, and laparoschisis 5.1%.

The predominance of musculoskeletal abnormalities was also reported in other countries [21, 22].

A study by Sakar et al. in India reported a similar prevalence of musculoskeletal abnormalities at 33% followed by abnormalities of digestive and central nervous systems [23].

In Egypt, the rate of musculoskeletal abnormalities is 8.82% (1.8 / 1000) [15].

A study by Dolk et al. in Europe indicated that limb abnormalities were more frequent (38 per 10,000 births) than neurological one (23 per 10,000 births) [24].

In Canada, the prevalence of limb malformations was estimated at 3.5 per 10,000 total births in 2007, and the prevalence of laparoschisis was 4.4 per 10,000 total births in 2009 [17].

CM of the nervous system was the second most reported in our study with a percentage of 18% (19 per 10,000 births). Out of these reported cases, 31% were of hydrocephalus (5.9 per 10,000 total births), 26.2% of anencephaly (versus 5 per 10,000 total births), 20.2% spina bifida (3.8 per 10,000 total births).

However some studies, such as those in Irak, India, Turkey and Ethiopia [20, 25,26,27], reported that neurological malformations ranked first with higher prevalence.

Similarly, a study conducted in Egypt between 1995 and 2009 reported a higher prevalence of neurological malformations at a rate of 55/10,000 and a lower prevalence of musculoskeletal abnormalities at 18/10,000 [15].

These differences in reported prevalence rates between studies reflect significant differences between populations, the environment and health policies of each country. They also reflect difference in collection period, recruitment mode or definition of congenital malformation cases.

In our study, the prevalence of neural tube defects is reported at 10 per 10,000 total births. This prevalence varies between countries from a low 4.1 per 10,000 births in Canada [17] to a high 12.8 per 10,000 births in England and Wales [28] while, in the European Union, the current prevalence of neural tube defects (NTD) was estimated at 10.8 (9.80–10.36) per 10,000 births between 2011 and 2017 according to the latest results published by EUROCAT [29].

The prevalence remains high in developing countries while it has gone down significantly in countries which implemented NTD prevention policies including folic acid supplementation and prenatal NTD screening and pregnancy interruption for severe cases [17].

In Morocco, the ministry of health started a folic acid supplementation strategy in 2008 according to a protocol which specifies a supplementation of 400 μg of vitamin B9 to parturient women while for epileptic under-treatment women (sodium valproate, carbamazepine) and women with a history of neural tube closure abnormalities (an affected newborn or family cases) the protocol specifies a 5 mg/day dose 2 months prior to conceiving and during the first 3 months of pregnancy.

Genetic abnormalities represent 8.5% (9 per 10,000 total births), 87.5% of which are Down syndrome (8 per 10,000 total births). In Egypt, these genetic abnormalities represent 25% (5,1/1000 total births), 74.49% of which are Down syndrome [15].

The prevalence of Down syndrome in our study is lower than those reported by others. Indeed, A study conducted in the Rhône-Alpes region over the 1981–2009 period showed a prevalence of 28.7 per 10,000. In addition, a study covering the population of Paris region between 1981 and 2007 estimated the total prevalence of Down syndrome at 30.6 per 10,000 while the prevalence among live births was 8.9 per 10,000; a difference is mainly due to prenatal screening and medical termination of pregnancy (MTP).

The high prevalence of Down syndrome in developed country is attributable to the advanced maternal age at procreation and early screening policies [30].

The screening for Down syndrome is not generalized in Morocco which does not have a chromosomal screening policy in place. In addition, pregnancy interruption is not legally permitted.

The antenatal screening for congenital malformations is not systematic in developing countries, including Morocco, as it is not integrated in national health programs. This explains the low rate of antenatal diagnosis in our study which stands at 28.6% of cases, of which 5.7% (4 cases) were diagnosed in the 1st trimester, 47% (33 cases) in the 2nd trimester and 48.5% in the 3rd trimester.

The antenatal diagnoses performed during the 3rd trimester a related to pregnant women who were initially under the care of other health structures where no early screening was carried out, in addition to women who only sought medical care when they reached their 3rd trimester.

This delay in antenatal diagnosis of congenital malformations is also reported in other studies covering developing countries with, for example, a median gestational age of 31 weeks in Saudi Arabia and 32 weeks in Kenya [31, 32].

In more than two thirds of cases (71.4%), the diagnosis was made at birth during the systematic clinical examination of newborn infants.

In our study, 26.5% of births with malformation presented a polymalformative syndrome. Seven groups of malformation associations were identified through principal component analysis. These associations can explain 21% of the malformation variability in the studied population. The 3 main associations represent more than 50% of the total variance. These 3 associations include, among other malformations, the VACTERL/VATER combination, a group of congenital malformations including vertebral “V”, anorectal “A”, cardiovascular “C”, tracheo-esophageal “TE”, renal “R” and limbs “L”.

The diagnosis of VACTERL association can only be confirmed once at least 3 of the above-mentioned congenital malformations are identified in a patient [33, 34].

Study limitations

This study allowed us to estimate the prevalence of congenital malformations in the case of Morocco. However, this result is probably understating the reality of the national epidemiological situation since the malformation census is not systematically performed throughout the country. In addition, health programs have not integrated routine prenatal screening for CM and do not consider this problem a priority at this time. Moreover, some late-onset malformations, posterior to neonatal period, will not be counted in the census.

Finally, the insufficient description of some congenital malformation cases lead to a general under-reporting of malformations.


The present study evaluated the prevalence of CMs at the “Les Orangers” Maternal and Reproductive Health Hospital in Rabat, and determined the different types and existing associations of these malformations between January 1st 2011 and June 31st 2016.

It represents an epidemiological database that should be complemented by other multicenter studies to determine the prevalence of congenital malformations at a national level.

Indeed, it is a imperative to ensure the monitoring of CMs and the accurate evaluation of their general prevalence and distribution in order to assess the burden on the population as well as the health system and select the appropriate preventive measures.

Furthermore, the registration and monitoring of CMs in our country should be established as a whole program including a congenital anomalies registry as part of the national health information system and a teratovigilance network. This will allow to consider a national and/or regional strategy for antenatal diagnosis, genetic counseling and prevention of CMs. Additionally, it will enable a better management of newborns with congenital anomalies from birth.

Availability of data and materials

Data is available upon reasonable request.



Congenital malformations


World health organization


National Survey of Population and Family Health


European surveillance of congenital anomalies


International clearinghouse for birth defects surveillance and research


Acronym for vertebral, anal, cardiac, tracheal, esophageal, radial, and/or renal malformations


Principal component analysis


Fetal death in-utero


Centers for Disease Control and Prevention


Neural tube defects


Medical termination of pregnancy


Confidence interval


International classification of diseases


  1. 1.

    REMERA: Registre des malformations en Rhône Alpes, Situation du registre en 2011, Rapport d’activités. Données naissances 2010.

    Google Scholar 

  2. 2.

    Les malformations congénitales en Rhône-Alpes: Les dossiers santé-environnement de l’ors Août 2012 - n°8, Observatoire Régional de la Santé Rhône-Alpes.

  3. 3.

    Hatton F, Bouvier-Colle MH, Blondel B, Pequignot F, Letoullec A. Evolution de la mortalité infantile en France: fréquence et causes de 1950 à 1997. Arch Pédiatr. 2000;7:239–44.

    Article  Google Scholar 

  4. 4.

    Lee K, Khoshnood B, Chen L, Wall SN, Cromie WJ, Mittendor RL. Infant mortality from congenital malformations in the United States, 1970-1997. Obstet Gynecol. 2001;98:620–9.

    CAS  PubMed  Google Scholar 

  5. 5.

    Liu S, Joseph KS, Kramer MS, Allen AC, Sauve R, Rusen ID, Wen SW. Fetal and infant health study Group of the Canadien Perinatal Surveillance system. Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada. JAMA. 2002;287:1561–7.

    Article  Google Scholar 

  6. 6.

    Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry. 1994;31:188–205.

    CAS  PubMed  Google Scholar 

  7. 7.

    Stevenson RE. Human Malformations and related anomalies. New York: New York University Press; 1993. p. 115.

    Google Scholar 

  8. 8.

    Enquête Nationale sur la Population et la Santé Familiale (ENPSF). Rapport Préliminaire. Rabat: Ministère de la Santé, DPRF/DPE/SEIS; 2018.

    Google Scholar 

  9. 9.

    Bérénice DORAY. Epidémiologie, clinique, génétique et prévention des malformations congénitales, Registre des malformations congénitales d’Alsace 1995–2009. Thèse, Université de Strasbourg, ECOLE DOCTORALE des sciences de la vie et de la santé, 25 Juillet 2013.

    Google Scholar 

  10. 10.

    Lelong N, Thieulin A-C, Vodovar V, Goffinet F, Khoshnood B. Surveillance épidémiologique et diagnostic prénatal des malformations congénitales en population parisienne: évolution sur 27 ans, 1981-2007. Arch Pediatr. 2012;19:1030–8.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Pathologie du développement: malformations congénitales 2011–2012. Collège Français des Pathologistes (CoPath).

  12. 12.

    CIM-10 FR, Classification Statistique Internationale des Maladies et des Problèmes de santé connexes. Rapport de la conférence internationale, volume 1, édition 2017.

    Google Scholar 

  13. 13.

    Toni LK. ETUDE DES MALFORMATIONS CONGENITALES CLINIQUEMENT VISIBLES A LA NAISSANCE A LUBUMBASHI. Mémoire, Université de Lubumbashi, Faculté de Médecine, année; 2010–2011.

    Google Scholar 

  14. 14.

    Tabu G. Profil des malformations congénitales apparentes à Kinshasa. Mémoire de Spécialisation: Université de Kinshasa; 2004.

  15. 15.

    Shawky RM, Sadik DI. Congenital malformations prevalent among Egyptien children and associated risk factors. Egyptian J Med Hum Genet. 2011;12:69–78.

  16. 16.

    De Vigan C, Khoshnood B, Cadio E, Vodovar V, Goffinet F. Le Registre des malformations de Paris: un outil pour la surveillance des malformations et l’évaluation de leur prise en charge. Inserm, UMR S149, IFR 69, Unité de recherche épidémiologique en santé périnatale et santé des femmes, Paris, France. Paris. BEH thématique 28–29 / 8 juillet: UPMC, Université Paris 6, UMR S149; 2008.

    Google Scholar 

  17. 17.

    Taylor G. Les anomalies congénitales au CANADA 2013, Rapport de surveillance sur la santé périnatale. Ottawa: Agence de la santé publique du CANADA; 2013.

    Google Scholar 

  18. 18.

    Le MT, Shumate CJ, Hoyt AT, Wilkinson AV, Canfield MA. The prevalence of birth defects among non-Hispanic Asian/Pacific islanders and American Indians/Alaska natives in Texas, 1999–2015. Birth Defects Res. 2019:1–9.

  19. 19.

    Penchaszadeh VB. Preventing congenital anomalies in developing countries. Community Genet. 2002;5:61–9.

    Article  PubMed  Google Scholar 

  20. 20.

    Ameen SK, Alalaf SK, Shabila NP. Pattern of congenital anomalies at birth and their correlations with maternal characteristics in the maternity teaching hospital, Erbil city, Iraq. BMC Pregnancy Childbirth. 2018;18:501.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Soudabeh V, Mina J, Samaneh S, Mina A, Mohammad M. Prevalence of congenital anomalies in Iran: A review article. Iran J Public Health. 2017;46(6):733–43.

    Google Scholar 

  22. 22.

    Vishnu Bhat B, Babu L. Congenital malformations at birth — A prospective study from south India. Indian J Pediatr. 1998;65:873–81.

    Article  Google Scholar 

  23. 23.

    Sarkar S, Patra C, Dasgupta MK, et al. Prevalence of congenital anomalies in neonates and associated risk factors in a tertiary care hospital in eastern India. J Clin Neonatol. 2013;2:131–4.

    Article  Google Scholar 

  24. 24.

    Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010:349–64.

  25. 25.

    Bhide P, Kar A. A national estimate of the birth prevalence of congenital anomalies in India: systematic review and meta-analysis. BMC Pediatrics. 2018;18:175.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Himmetoglu MB, Tiras RG, Karabacak O, Sahin I, Onan A. The incidence of congenital malformations in a Turkish population. Int J Gynecol Obstet. 1996;55:117–21.

    CAS  Article  Google Scholar 

  27. 27.

    Taye M, Afework M, Fantaye W, Diro E, Worku A. Congenital anomalies prevalence in Addis Ababa and the Amhara region, Ethiopia: a descriptive cross-sectional study. BMC Pediatrics. 2019;19:234.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Morris JK, Rankin J, Draper ES, Kurinczuk JJ, Springett A, Tucker D, Wellesley D, Wreyford B, Wald NJ. Prevention of neural tube defects in the UK: a missed opportunity. Arch Dis Child. 2016;101:604–7.

    CAS  Article  PubMed  Google Scholar 

  29. 29. Accessed 20 April 2020.

  30. 30.

    Gimeno-Martos HS, Cavero-Carbonell C, López-Maside A, Bosch-Sánchez S, Martos-Jiménez C, Zurriaga O. Chromosomal anomalies: The experience of the Congenital Anomalies Registry of the Valencia Region. An Pediatr (Barc). 2016;84(4):203–10.

    CAS  Article  Google Scholar 

  31. 31.

    A-HM SBI, Attyyaa RA, et al. Antenatal diagnosis, prevalence and outcome of major congenital anomalies in Saudi Arabia: a hospital-based study. Ann Saudi Med. 2008;28(4):272–6.

    Article  Google Scholar 

  32. 32.

    Onyambu CK, Tharamba NM. Screening for congenital fetal anomalies in low risk pregnancy: the Kenyatta National Hospital experience. BMC Pregnancy Childbirth. 2018;18:180.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Stevenson RE, Hunter AGW. Considering the Embryopathogenesis of VACTERL association. Mol Syndromol. 2013;4:7–15.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Padma S, Sundaram PS, Sonik B. A case of VACTERL and non-VACTERL association without the “V and L”. Indian J Nucl Med. 2014;29(I):46.

    CAS  Article  Google Scholar 

Download references


We would like to thank everyone who has contributed to this study.


Not applicable.

Author information




ATI was responsible for the study concept and design. KF coordinated the study and interviewed the parents. KF and EB analyzed the data. KF led the drafting of this manuscript, with input from all authors. ATI and MHA supervised analysis of the data and contributed to the writing. MS contributed to the revision of English. ATI, MHA, EB, MS and AMA contributed to revision and final approval of the manuscript. All the authors have approved the present version of the manuscript.

Corresponding author

Correspondence to K. Forci.

Ethics declarations

Ethics approval and consent to participate

The Ethical Committee of Biological Research, Faculty of Medicine and Pharmacy – Rabat, approved the study. The oral consent to participate was obtained from the parents.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Forci, K., Alami, M.H., Bouaiti, E. et al. Prevalence of congenital malformations at the “les Orangers” maternity and reproductive health Hospital of Rabat: descriptive study of 470 anomalies. BMC Pediatr 20, 272 (2020).

Download citation


  • Congenital malformation
  • Prevalence
  • Association
  • Antenatal diagnosis
  • Morocco